But there was a 61% difference in the rates of major adverse cardiac events at 6 months: 7.8% with the coated stent and 20% with the bare metal stent
. And again, that difference was accounted for primarily by a 67% lower rate of target vessel revascularization and an 80% lower rate of target lesion revascularization in the patients who received moderate-release paclitaxel-eluting stents.
An unexpected finding was the marked difference between groups in the secondary combined end point of major adverse cardiovascular events, consisting of death, MI, cerebrovascular accident, or target lesion revascularization: 31.3% in the bare metal stent
Each year, approximately 166,000 angioplasties are performed in Japan, and 70% of them undergo treatment with conventional bare metal stents
"We are seeing a significant migration from bare metal stents
to drug-eluting stents in the interventional cardiology arena.
Although the court allowed [this], in the written order it said that the prices of stents should be Rs20,000 for bare metal stents
and Rs60,000 for third generation stents,' he said.
"Bare metal stents
are seldom used, and are often saved for use only in high-bleeding risk and elderly patients due to concerns of bleeding from dual anti-platelet therapy after DES implantation," noted Tim Girton, vice president of Interventional Cardiology research and development at Boston Scientific Corp.
According to an official notification, a central purchase committee supervised the bid and new rates were approved at Rs30,500 for drug-eluting stents and Rs13,250 for bare metal stents
Background and Objective: Everolimus-eluting stents, compared with bare metal stents
, reduced the risk of restenosis in clinical trials with strict inclusion and exclusion criteria.
The recent studies suggest that there is a higher risk of blood clots forming in medicine-coated stents compared to bare metal stents
and the Food and Drug Administration (FDA) reports that medicine-coated stents usually don't cause complications due to blood clots when used as recommended, Dr.
The global coronary stents market segmentation is based on product types (Bare Metal Stents
, Drug Eluting Stents, Bio-absorbable Stents), and products in pipeline (CORACTO, EXCELLA II and EXCELLA BD, DESolve Nx and DESolve FIM, ZoMaxx I and ZoMaxx II, ABSORB STEMI, BioFreedom, TAXUS PERSEUS, BioNIR).